Clinical Trial Update: A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin [Phase 3]

View source ↗

Summary

Phase 3 study comparing fenofibrate versus ezetimibe as add-on therapy to atorvastatin in adults with hyperlipidemia; the 16-week trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• FENOFIBRATE (Fenofibrate)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Abbott | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED